This study aims to synthesize contemporary evidence on the benefits, risks, and emerging options in menopausal hormone therapy (MHT), emphasizing the recent literature. A narrative review of peer-reviewed studies and guidelines (up to September 2025) from major databases (e.g., MEDLINE/PubMed, Embase, Cochrane) was conducted, with emphasis on the last five years and qualitative synthesis. MHT provides the most effective relief of vasomotor symptoms and is the first-line treatment for genitourinary syndrome of menopause, particularly with the use of low-dose local vaginal estrogen preparations; it also prevents early postmenopausal bone loss and reduces fractures in selected cases. Cardiovascular prevention is not an indication. Benefit–risk depends on timing, route, and dose. Initiation within 10 years of menopause as well as the use of transdermal estradiol at low–moderate doses are favored when cardiometabolic or thrombotic risk is salient. In contrast, oral regimens—particularly those using conjugated equine estrogens—are associated with higher risks of venous thromboembolism and stroke compared with transdermal 17 β-estradiol, and risk also varies by the type of progestogen used. Effects on breast cancer risks are regimen-specific: neutral to favorable with estrogen-alone after hysterectomy, but increasing with longer use of combined therapy. While the absolute risk of ovarian cancer remains small, evidence for colorectal cancer remains mixed. MHT confers modest improvements in sleep, mood, intercourse, and quality of life. Estetrol (E4) shows anti-VMS efficacy at the minimum effective oral dose and favorable pharmacology, but conclusive data on its long-term cardiovascular, thrombotic, and breast safety are pending. MHT should be individualized appropriately based on the patient, timing, route, dose, and choice of progestogen. The lowest effective dose should be used, alongside periodically reassessing the therapy as new evidence, including emerging data on E4, emerges.
Peer reviewed research, study, or review.
Sign in to access
A concise overview of the report, distilling the complex research into a clear, compelling overview.
Sign in to access
Perfect for consultations, staff education, presentations, and social conversations.
Sign in to access
Common patient questions with evidence-based answers to help guide consultations.
Sign in to access
Ready-to-use social media content to engage your audience and establish thought leadership.
Sign in to access
Structured outlines for blog posts and articles to streamline your content creation.
Sign in to access
Peer reviewed research, study, or review.
Included with a subscription
A concise overview of the report, distilling the complex research into a clear, compelling overview.
Included with a subscription
Perfect for consultations, staff education, presentations, and social conversations.
Included with a subscription
Common patient questions with evidence-based answers to help guide consultations.
Included with a subscription
Structured outlines for blog posts and articles to streamline your content creation.
Included with a subscription
Full-length articles ready to publish on your website or blog.
Included with a subscription
Comprehensive video scripts for educational content and detailed explanations.
Included with a subscription
Bite-sized video scripts perfect for social media platforms and quick educational content.
Included with a subscription
Printable patient education materials for your waiting room and consultations.
Included with a subscription
Email-ready content to keep your patients informed and engaged.
Included with a subscription
12 Additional Social Media Posts with beautiful, ready-to-post images included
Included with a subscription